Prediction: Will SoFi Stock Double This Year Amid Growth
SoFi Technologies reports strong Q1 2026 results, highlighting revenue growth and expanding membership, while the sto...
Q1 2026
This page aggregates 8 Q1 2026 earnings articles, from previews to transcripts and takeaways, to help you compare companies and plan investments.
63 articles
American Express Stock at $315: Buy, Hold or Sell Now
American Express trades around $315 as Q1 2026 results highlight growth in card member spending and improving credit ...
Bosc 2026 Earnings Transcript: Q1 Deep Dive for Investors
A focused look at the BOSC 2026 earnings transcript for Q1. This article breaks down revenue trends, margin health, a...
Crypto Funding Falls After Q4 2025 Surge, Q1 2026 Slows
New Galaxy Digital figures show crypto funding falls after the Q4 2025 spike, as Q1 2026 totals pull back though rema...
Chagee (CHA) 2026 Earnings: Q1 Insights and Investor Guide
A fresh, reader-friendly breakdown of Chagee's Q1 2026 earnings. We unpack revenue drivers, margins, and guidance to ...
Gorilla (GRRR) 2026 Earnings: Q1 Deep Dive and Outlook
Gorilla's Q1 2026 results shed light on the company’s growth trajectory and profitability path. This deep dive breaks...
Auto (LI) 2026 Earnings Outlook for Li Auto Investors
Li Auto's 2026 earnings outlook hinges on shipments, margins, and smart capital allocation. This deep dive breaks dow...
Kingsoft Cloud KC 2026 Q1 Earnings Outlook and Trends
Kingsoft Cloud KC 2026 Q1 sets the tone for the year. This guide breaks down what to watch in margins, segments, and ...
(NRXP) 2026 Earnings Call: What Investors Should Watch
The (nrxp) 2026 earnings call highlights a shifting biotech landscape. This article breaks down what the results mean...
Aurora Mobile 2026 Earnings: Q1 Insights, Guidance & Roadmap
Aurora Mobile's Q1 2026 earnings reveal a mix of solid growth and evolving margins. This piece breaks down what the t...
Auna (Auna) 2026 Earnings: Key Read on Growth and Risks
Auna's Q1 2026 earnings signal a mixed yet resilient growth path. This analysis breaks down revenue, margins, and gui...
Forget Moderna: This Biotech Juggernaut Is Rising Fast
A biotech powerhouse is drawing fresh attention as Moderna slows, delivering stronger cash flow, patent extensions, a...